AI assistant
ProPhase Labs, Inc. — Director's Dealing 2023
Feb 2, 2023
34999_dirs_2023-02-02_c2ea828b-f6f2-4518-a0b3-f50a73e5b1f0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2023-02-01
Reporting Person: Karkus Ted William (Director, CEO & CHAIRMAN, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-01 | Common Stock, par value $0.005 | M | 500000 | $0.6 | Acquired | 3852087 | Direct |
| 2023-02-01 | Common Stock, par value $0.005 | F | 268337 | $8.18 | Disposed | 3583750 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-01 | Option (right to buy) | $0.6 | M | 500000 | Disposed | 2023-02-22 | Common Stock (500000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.005 | 100000 | Indirect |
Footnotes
F1: On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes.
F2: The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.